Otsuka has claimed FDA approval for its IgA nephropathy (IgAN) therapy Voyxact, joining an increasingly crowded market and beating rival Vera Therapeutics to the punch. Anti-APRIL antibody Voyxact ...
The official source for NFL news, video highlights, fantasy football, game-day coverage, schedules, stats, scores and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback